CAR-T-ICI: COMBINATION OF CHIMERIC ANTIGEN RECEPTOR T-CELL WITH ANTI PD-1 IMMUNE CHECKPOINT INHIBITOR AS A NOVEL TREATMENT FOR COLORECTAL CANCER: Combination of chimeric antigen receptor T-cell with anti PD-1 immune checkpoint inhibitor as a novel treatment for colorectal cancer. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, [S. l.], v. 9, n. 1, p. 56–68, 2021. DOI: 10.53366/jimki.v9i1.339. Disponível em: https://jimki.bapin.or.id/main/article/view/339. Acesso em: 19 may. 2026.